Literature DB >> 10361560

Supportive care, pain management, and quality of life in advanced prostate cancer.

P Esper1, B G Redman.   

Abstract

Despite achievements in the area of providing care for patients with advanced prostate cancer, ample work remains. Additional research is needed regarding the control of pain from bone metastases and the management of fatigue and urinary symptoms. Investigators have only begun to explore the area of quality of life research in patients with prostate cancer. Other issues not addressed in this article that are significant to the care of these patients include caregiver burden and end-of-life care. These areas significantly affect quality of life. The supportive care, pain management, and quality of life issues discussed herein present many challenges to health care providers. Close attention to what patients tell us about their care will make the challenge more attainable and the caregiving more satisfying.

Entities:  

Mesh:

Year:  1999        PMID: 10361560     DOI: 10.1016/s0094-0143(05)70077-x

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

1.  A multidisciplinary approach to the management of hormone-refractory prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

2.  Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.

Authors:  Jeffrey G Nalesnik; Angela G Mysliwiec; Edith Canby-Hagino
Journal:  Rev Urol       Date:  2004

3.  A multidisciplinary approach to the management of hormone-refractory prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

4.  The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.

Authors:  Florian Scotté
Journal:  Oncologist       Date:  2012

5.  Update in palliative management of hormone refractory cancer of prostate.

Authors:  Pratipal Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2007-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.